Skip to main content
Top
Published in: Abdominal Radiology 6/2014

01-12-2014

Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI?

Authors: Najwa Al Ansari, Bong Soo Kim, Saowanee Srirattanapong, Charles T. A. Semelka, Miguel Ramalho, Ersan Altun, John T. Woosley, Benjamin Calvo, Richard C. Semelka

Published in: Abdominal Radiology | Issue 6/2014

Login to get access

Abstract

Purpose

To determine MR features suggestive of mass-forming cholangiocarcinoma (CCA) or liver metastases of adenocarcinoma of unknown primary (AUP), and to compare the ability of two experienced radiologists to establish the correct diagnosis.

Materials and methods

61 patients with CCA or AUP, with MRIs were placed into two groups: population 1, 28 patients with certain diagnosis of either CCA or AUP; and population 2, 33 patients with uncertain diagnosis. Using population 1 with known diagnosis, two investigators formulated imaging criteria for CCA or AUP, which represented phase 1 of the study. In phase 2, two independent radiologists categorized the patients in populations 1 and 2 as CCA or AUP using the formulated criteria. This categorization was compared with the patient medical records and pathologist review. Findings were tested for statistical significance.

Results

In phase 1, solitary lesion, multifocal lesions with dominant lesion, capsule retraction, and porta hepatis lymphadenopathy were features of CCA; multifocal lesions with similar size, and ring enhancement were features of AUP. The number of lesions, capsule retraction, and early tumor enhancement pattern were observed to be significant features (P < 0.05). In phase 2, agreement between the two radiologists was good (k = 0.663). For population 1, the agreement was good (k = 0.659), and was fair for population 2 (k = 0.293). Concordance between the two radiologists, medical record, and the pathologist was found in 41/61 (67%) patients.

Conclusion

Distinctive features of CCA and AUP are identifiable on MRI images, which may aid the radiologist to establish the correct diagnosis.
Literature
1.
go back to reference Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33(6):1353–1357PubMedCrossRef Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33(6):1353–1357PubMedCrossRef
2.
3.
go back to reference Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef
4.
go back to reference Burak K, Angulo P, Pasha TM, et al. (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99:523–526PubMedCrossRef Burak K, Angulo P, Pasha TM, et al. (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99:523–526PubMedCrossRef
5.
go back to reference Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Am J Roentgenol 181:819–827CrossRef Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Am J Roentgenol 181:819–827CrossRef
6.
go back to reference Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern—correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern—correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef
7.
go back to reference Braga L, Semelka RC, Danet I-M, Venkataraman S, Woosley JT (2003) Liver metastases from unknown primary site: demonstration on MR images. Magn Reson Imaging 21:871–877PubMedCrossRef Braga L, Semelka RC, Danet I-M, Venkataraman S, Woosley JT (2003) Liver metastases from unknown primary site: demonstration on MR images. Magn Reson Imaging 21:871–877PubMedCrossRef
8.
go back to reference Nystrom JSWJ, Heffelfinger-Juttner J, Irwin LE, Baterman JRWR (1977) Metastatic and histologic presentation in unknown primary cancer. Semin Oncol 4:53–58PubMed Nystrom JSWJ, Heffelfinger-Juttner J, Irwin LE, Baterman JRWR (1977) Metastatic and histologic presentation in unknown primary cancer. Semin Oncol 4:53–58PubMed
9.
go back to reference Le Chevalier TCE, Caille P, Harvey J, et al. (1998) Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 148:2035–2039CrossRef Le Chevalier TCE, Caille P, Harvey J, et al. (1998) Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 148:2035–2039CrossRef
10.
go back to reference Tickoo SK, Zee SY, Obiekwe S, et al. (2002) Combined hepatocellular-cholangiocarcinoma: a histopathologic, Immunohistochemical, and in situ hybridization study. Am J Surg Pathol 26:989–997PubMedCrossRef Tickoo SK, Zee SY, Obiekwe S, et al. (2002) Combined hepatocellular-cholangiocarcinoma: a histopathologic, Immunohistochemical, and in situ hybridization study. Am J Surg Pathol 26:989–997PubMedCrossRef
11.
go back to reference Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 14(379):428–435 Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 14(379):428–435
12.
go back to reference Lazaridis G, Pentheroudakis G, Fountzilas G, Pavlidis N (2008) Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature. Cancer Treat Rev 34:693–700PubMedCrossRef Lazaridis G, Pentheroudakis G, Fountzilas G, Pavlidis N (2008) Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature. Cancer Treat Rev 34:693–700PubMedCrossRef
13.
go back to reference Saiura A, Yamamoto J, Kokudo N, et al. (2011) Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg 201:203–208PubMedCrossRef Saiura A, Yamamoto J, Kokudo N, et al. (2011) Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg 201:203–208PubMedCrossRef
14.
go back to reference Morimoto Y, Tanaka Y, Ito T, et al. (2003) Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:432–440PubMedCrossRef Morimoto Y, Tanaka Y, Ito T, et al. (2003) Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:432–440PubMedCrossRef
15.
go back to reference Shimonishi T, Miyazaki K, Nakanuma Y (2000) Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 37:55–63PubMedCrossRef Shimonishi T, Miyazaki K, Nakanuma Y (2000) Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 37:55–63PubMedCrossRef
16.
go back to reference El Rassi ZE, Partensky C, Scoazec JY, et al. (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25:375–380PubMedCrossRef El Rassi ZE, Partensky C, Scoazec JY, et al. (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25:375–380PubMedCrossRef
17.
go back to reference Maeda TKK, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M (1996) The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901–909PubMed Maeda TKK, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M (1996) The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901–909PubMed
18.
go back to reference Bugat R, Bataillard A, Lesimple T, et al. (2003) Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site. Br J Cancer 89:S59–S66PubMedCentralPubMedCrossRef Bugat R, Bataillard A, Lesimple T, et al. (2003) Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site. Br J Cancer 89:S59–S66PubMedCentralPubMedCrossRef
19.
go back to reference Sasaki A, Kawano K, Aramaki M, et al. (1999) Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver. Journal of Surgical Oncology 70:103–108PubMedCrossRef Sasaki A, Kawano K, Aramaki M, et al. (1999) Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver. Journal of Surgical Oncology 70:103–108PubMedCrossRef
20.
go back to reference Alastair D, Burt BCP, Ferrell LD (2008) MacSween’s pathology of the liver, 5th edn. Philadelphia: Churchill Livingston Alastair D, Burt BCP, Ferrell LD (2008) MacSween’s pathology of the liver, 5th edn. Philadelphia: Churchill Livingston
21.
go back to reference Chung YE, Kim M-J, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683–700PubMedCrossRef Chung YE, Kim M-J, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683–700PubMedCrossRef
22.
go back to reference Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167:689–693PubMedCrossRef Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167:689–693PubMedCrossRef
23.
go back to reference Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540–547PubMed Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540–547PubMed
24.
go back to reference Lee WJ, Lim HK, Jang KM, et al. (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21:S97–S116PubMedCrossRef Lee WJ, Lim HK, Jang KM, et al. (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21:S97–S116PubMedCrossRef
25.
go back to reference Buc E, Lesurtel M, Belghiti J (2008) Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB 10:98–105PubMedCentralPubMedCrossRef Buc E, Lesurtel M, Belghiti J (2008) Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB 10:98–105PubMedCentralPubMedCrossRef
26.
go back to reference Rullier A, Le Bail B, Fawaz R, et al. (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24:870–876PubMedCrossRef Rullier A, Le Bail B, Fawaz R, et al. (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24:870–876PubMedCrossRef
27.
go back to reference Choi BI, Lee JM, Han JK (2004) Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging 29:548–557PubMed Choi BI, Lee JM, Han JK (2004) Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging 29:548–557PubMed
28.
go back to reference Khan SA, Davidson BR, Goldin R, et al. (2005) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51:VI1–9 Khan SA, Davidson BR, Goldin R, et al. (2005) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51:VI1–9
29.
go back to reference Valls C, Gumà A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef Valls C, Gumà A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef
30.
go back to reference Danet I-M, Semelka RC, Leonardou P, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. Am J Roentgenol 181:809–817CrossRef Danet I-M, Semelka RC, Leonardou P, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. Am J Roentgenol 181:809–817CrossRef
31.
go back to reference Nanashima A, Sumida Y, Abo T, et al. (2008) Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 98:535–539PubMedCrossRef Nanashima A, Sumida Y, Abo T, et al. (2008) Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 98:535–539PubMedCrossRef
32.
go back to reference Chiu CT, Chiang JM, et al. (2008) Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Dig Liver Dis 40:749–754PubMedCrossRef Chiu CT, Chiang JM, et al. (2008) Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Dig Liver Dis 40:749–754PubMedCrossRef
33.
go back to reference Maithel SK, Gamblin TC, Kamel I, et al. (2013) Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 119:3929–3942PubMedCrossRef Maithel SK, Gamblin TC, Kamel I, et al. (2013) Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 119:3929–3942PubMedCrossRef
34.
go back to reference Ishida H, Ishibashi K, Ohsawa T, et al. (2011) Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer. Int Surg 96:291–299PubMedCrossRef Ishida H, Ishibashi K, Ohsawa T, et al. (2011) Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer. Int Surg 96:291–299PubMedCrossRef
35.
go back to reference Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. Am J Roentgenol 162:1119–1122CrossRef Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. Am J Roentgenol 162:1119–1122CrossRef
36.
go back to reference Jeong HT, Kim MJ, Chung YE, et al. (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. Am J Roentgenol 201:W603–W611CrossRef Jeong HT, Kim MJ, Chung YE, et al. (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. Am J Roentgenol 201:W603–W611CrossRef
37.
go back to reference Jhaveri KS, Halankar J, Aguirre D, et al. (2009) Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. Am J Roentgenol 193:752–756CrossRef Jhaveri KS, Halankar J, Aguirre D, et al. (2009) Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. Am J Roentgenol 193:752–756CrossRef
Metadata
Title
Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI?
Authors
Najwa Al Ansari
Bong Soo Kim
Saowanee Srirattanapong
Charles T. A. Semelka
Miguel Ramalho
Ersan Altun
John T. Woosley
Benjamin Calvo
Richard C. Semelka
Publication date
01-12-2014
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2014
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0172-3

Other articles of this Issue 6/2014

Abdominal Radiology 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.